Toca­gen li­cens­es im­munother­a­py to Apol­lo­Bio for $16M up­front; WuXi AppTec un­veils ex­pand­ed lab test­ing site in New Jer­sey

→ San Diego-based Toca­gen $TO­CA has inked a li­cens­ing deal with Apol­lo­Bio, giv­ing an af­fil­i­ate of the Bei­jing-based com­pa­ny an ex­clu­sive li­cense to de­vel­op and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER